Artificial Intelligence in Genomics Market Size | CAGR of 16.1%

<h2>Report Overview</h2>
The <strong>Global Artificial Intelligence In Genomics Market</strong> was valued at <strong>USD 1.5 Bn</strong> in 2023. It is expected to reach <strong>USD 6.4 Bn</strong> by 2033, with a <strong>CAGR of 16.1% </strong>during the forecast period from 2024 to 2033.

The Artificial Intelligence in Genomics Market involves the application of advanced AI technologies, including machine learning and deep learning, to the analysis and interpretation of complex genomic data. This market is revolutionizing the field of genomics by enabling more accurate and efficient identification of genetic mutations, disease risks, and personalized treatment options. With the rapid growth in genomic data and the increasing need for precision medicine, AI-driven solutions are becoming integral to advancing research, diagnostics, and therapeutics in genomics, positioning this market for significant expansion and innovation in the coming years.

<img class="aligncenter wp-image-50393" src="https://marketresearch.biz/wp-content/uploads/2024/08/Artificial-Intelligence-in-Genomics-Market-Growth-Analysis.jpg" alt="Artificial Intelligence in Genomics Market Growth Analysis" width="744" height="418">

The integration of artificial intelligence in genomics is fundamentally reshaping the landscape of genetic research and healthcare. AI's ability to process and analyze vast quantities of genomic data with unprecedented speed and accuracy is driving breakthroughs in disease understanding and treatment development. A prime example is the AI-driven metagenomic analysis that identified diverse vertebrate hosts and Plasmodium parasites in 1,142 Anopheles gambiae mosquito specimens. This demonstrates the critical role AI plays in advancing genomic research, particularly in understanding and combating vector-borne diseases, which remain a significant global health challenge.

Looking ahead, the role of AI in genomics is expected to be a focal point at the 2024 PQG Conference at Harvard. The conference will spotlight the integration of cutting-edge AI technologies such as transformers, large language models, and protein structure models in genomics. These advancements underscore the potential of AI to revolutionize healthcare outcomes by enabling more precise and personalized medical interventions. The growing incorporation of AI in genomics is not just enhancing research capabilities but also accelerating the translation of genomic insights into practical healthcare solutions.

As the Artificial Intelligence in Genomics Market continues to evolve, it is poised to drive significant innovations in <a href="https://marketresearch.biz/report/personalized-medicine-market/">personalized medicine</a>, <a href="https://marketresearch.biz/report/drug-discovery-services-market/">drug discovery services</a>, and public health. The ability to leverage AI for the rapid analysis of complex genomic data will be pivotal in addressing some of the most pressing health issues of our time, making AI an indispensable tool in the future of genomic research and healthcare delivery.

<h2>报告概览</h2>

在全球基因组学人工智能市场中，2023年的市场规模达到<em>15亿美元</em>。预计到2033年将增至<em>64亿美元</em>，在2024年至2033年的预测期间，年复合增长率（CAGR）将达到16.1%。

基因组学人工智能市场涉及将高级人工智能技术，包括机器学习和深度学习，应用于复杂基因组数据的分析和解读。该市场通过实现更精确和高效的遗传突变、疾病风险以及个性化治疗方案的识别，正在革新基因组学领域。随着基因组数据的快速增长以及对精准医疗需求的增加，以人工智能驱动的解决方案正日益成为推动基因组学研究和诊断、治疗进步的关键因素，为未来几年该市场的显著扩张和创新奠定基础。

<img class="aligncenter wp-image-50393" src="https://marketresearch.biz/wp-content/uploads/2024/08/Artificial-Intelligence-in-Genomics-Market-Growth-Analysis.jpg" alt="基因组学人工智能市场增长分析" width="744" height="418">

人工智能在基因组学中的整合从根本上重塑了遗传研究和医疗保健的格局。人工智能能够以前所未有的速度和准确性处理和分析大量基因组数据，推动疾病理解和治疗开发的突破。一个典型的例子是，通过人工智能驱动的宏基因组分析，在1,142只按蚊标本中确定了多种脊椎动物宿主和疟原虫寄生虫。这证明了人工智能在推进基因组学研究中的关键作用，特别是在理解和应对媒介传播疾病，这些疾病仍然是全球公共卫生的重大挑战。

展望未来，人工智能在基因组学中的作用预计将成为2024年哈佛大学PQG会议的焦点。会议将重点介绍将前沿人工智能技术，如Transformer、大语言模型和蛋白质结构模型整合到基因组学中。这些进步凸显了人工智能通过实现更精确和个性化的医疗干预，革命性地改变医疗保健结果的前景。人工智能在基因组学中的日益普及不仅增强了研究能力，还加速了基因组洞见向实际医疗解决方案的转化。

随着基因组学人工智能市场的持续演变，它预计将在个性化医疗、药物发现服务和公共卫生等领域推动重大的创新。利用人工智能快速分析复杂基因组数据的能力，将在解决我们时代一些最紧迫的健康问题中发挥关键作用，使人工智能成为基因组研究和医疗保健提供未来不可或缺的工具。